| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: E9AHL4
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 140 | 144 | PF00656 | 0.635 |
| CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.354 |
| CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.542 |
| CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.354 |
| CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.533 |
| CLV_PCSK_PC7_1 | 56 | 62 | PF00082 | 0.482 |
| CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.494 |
| DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.398 |
| DOC_USP7_MATH_1 | 35 | 39 | PF00917 | 0.599 |
| DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.645 |
| DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.599 |
| DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.799 |
| DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.619 |
| LIG_14-3-3_CanoR_1 | 29 | 33 | PF00244 | 0.607 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.415 |
| LIG_FHA_1 | 5 | 11 | PF00498 | 0.293 |
| LIG_FHA_1 | 67 | 73 | PF00498 | 0.684 |
| LIG_FHA_2 | 1 | 7 | PF00498 | 0.404 |
| LIG_SH2_CRK | 102 | 106 | PF00017 | 0.605 |
| LIG_SH2_GRB2like | 117 | 120 | PF00017 | 0.704 |
| LIG_SH2_PTP2 | 17 | 20 | PF00017 | 0.304 |
| LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.310 |
| LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.589 |
| LIG_SH3_2 | 55 | 60 | PF14604 | 0.623 |
| LIG_SH3_3 | 101 | 107 | PF00018 | 0.598 |
| LIG_SH3_3 | 52 | 58 | PF00018 | 0.613 |
| LIG_SH3_3 | 65 | 71 | PF00018 | 0.561 |
| LIG_SUMO_SIM_anti_2 | 3 | 12 | PF11976 | 0.360 |
| LIG_TRAF2_1 | 132 | 135 | PF00917 | 0.638 |
| LIG_TYR_ITIM | 15 | 20 | PF00017 | 0.304 |
| MOD_CDC14_SPxK_1 | 57 | 60 | PF00782 | 0.625 |
| MOD_CDK_SPK_2 | 54 | 59 | PF00069 | 0.619 |
| MOD_CDK_SPxK_1 | 54 | 60 | PF00069 | 0.622 |
| MOD_CDK_SPxxK_3 | 54 | 61 | PF00069 | 0.624 |
| MOD_CK1_1 | 137 | 143 | PF00069 | 0.634 |
| MOD_GlcNHglycan | 122 | 127 | PF01048 | 0.444 |
| MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.465 |
| MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.420 |
| MOD_GSK3_1 | 50 | 57 | PF00069 | 0.705 |
| MOD_GSK3_1 | 62 | 69 | PF00069 | 0.709 |
| MOD_PIKK_1 | 50 | 56 | PF00454 | 0.682 |
| MOD_PKA_2 | 28 | 34 | PF00069 | 0.670 |
| MOD_Plk_1 | 113 | 119 | PF00069 | 0.638 |
| MOD_Plk_1 | 122 | 128 | PF00069 | 0.630 |
| MOD_Plk_4 | 113 | 119 | PF00069 | 0.668 |
| MOD_Plk_4 | 4 | 10 | PF00069 | 0.316 |
| MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.799 |
| MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.622 |
| TRG_DiLeu_BaEn_1 | 28 | 33 | PF01217 | 0.588 |
| TRG_ENDOCYTIC_2 | 102 | 105 | PF00928 | 0.608 |
| TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.310 |
| TRG_ER_diArg_1 | 58 | 61 | PF00400 | 0.728 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P382 | Leptomonas seymouri | 38% | 100% |
| A0A3S5H7Q1 | Leishmania donovani | 99% | 100% |
| E9AEF5 | Leishmania major | 90% | 100% |
| E9AIU5 | Leishmania braziliensis | 70% | 100% |
| E9B1Y3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |